The main department of described VC is located in the Oakland. The company was established in North America in United States.
Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2016. The higher amount of exits for fund were in 2018. The fund is generally included in less than 2 deals every year. Deals in the range of 1 - 5 millions dollars are the general things for fund. Opposing the other organizations, this Health Innovation Fund works on 12 percentage points less the average amount of lead investments.
Among the most successful fund investment fields, there are Medical, Hospital. For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FABPulous, Nightbalance. The fund has no exact preference in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Health Innovation Fund, startups are often financed by Thuja Capital, Limburg Ventures, Van Herk Ventures. The meaningful sponsors for the fund in investment in the same round are Thuja Capital, Limburg Ventures, Van Herk Ventures. In the next rounds fund is usually obtained by Thuja Capital, Sandbridge Capital, Limburg Ventures.
Related Funds
Fund Name | Location |
Aju Pharma | - |
Carefusion | California, San Diego, United States |
Cognicase | Canada, Montréal, Quebec |
EMV Capital | England, London, United Kingdom |
Libertas Capital | Beverly Hills, California, United States |
Media General | Sandston, United States, Virginia |
Ozone Ventures | - |
Sonder Capital | California, Redwood City, United States |
Suzhou Youcai Huiying Investment Center | China, Jiangsu, Suzhou |
Vestinwolf Alternatives | England, London, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Obatala Sciences | $1M | 22 Jan 2021 | New Orleans, Louisiana, United States | ||
Prolira BV | $2M | 01 Nov 2018 | Utrecht, Utrecht, Netherlands | ||
CirraGroup | $500K | 12 Jul 2016 | Lafayette, Louisiana, United States | ||
Nightbalance | $14M | 05 Jul 2016 | Delft, South Holland, Netherlands | ||
FABPulous | $2M | 04 Feb 2015 | Limburg | ||
DirectDerm | $240K | 06 Dec 2011 | California, United States | ||
FABPulous | 11 Jan 2010 | Limburg |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Obatala Sciences | $1M | 22 Jan 2021 | New Orleans, Louisiana, United States | ||
Prolira BV | $2M | 01 Nov 2018 | Utrecht, Utrecht, Netherlands | ||
CirraGroup | $500K | 12 Jul 2016 | Lafayette, Louisiana, United States | ||
Nightbalance | $14M | 05 Jul 2016 | Delft, South Holland, Netherlands | ||
FABPulous | $2M | 04 Feb 2015 | Limburg | ||
DirectDerm | $240K | 06 Dec 2011 | California, United States | ||
FABPulous | 11 Jan 2010 | Limburg |